|
CASP8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.71729297449019E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.25159948650389E-10 |
| Normal-vs-Stage2 |
3.813900E-04 |
| Normal-vs-Stage3 |
5.373000E-04 |
| Normal-vs-Stage4 |
4.982400E-02 |
| Stage1-vs-Stage2 |
2.061200E-01 |
| Stage1-vs-Stage3 |
4.323800E-01 |
| Stage1-vs-Stage4 |
7.698600E-01 |
| Stage2-vs-Stage3 |
6.820800E-01 |
| Stage2-vs-Stage4 |
3.122800E-01 |
| Stage3-vs-Stage4 |
5.190200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.94035931555936E-12 |
| Normal-vs-AfricanAmerican |
7.51490000228117E-08 |
| Normal-vs-Asian |
9.873600E-02 |
| Caucasian-vs-AfricanAmerican |
9.458600E-01 |
| Caucasian-vs-Asian |
3.320600E-01 |
| AfricanAmerican-vs-Asian |
3.157000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.42643707746038E-12 |
| Normal-vs-Female |
8.30699953269232E-10 |
| Male-vs-Female |
9.393900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.041350E-04 |
| Normal-vs-Extreme_Weight |
1.76465999999209E-05 |
| Normal-vs-Obese |
1.37659999954742E-07 |
| Normal-vs-Extreme_Obese |
1.842150E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.044600E-01 |
| Normal_Weight-vs-Obese |
3.367400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.891600E-01 |
| Extreme_Weight-vs-Obese |
2.862400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.903700E-02 |
| Obese-vs-Extreme_Obese |
7.911800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.43479999999719E-05 |
| Normal-vs-Age(41-60Yrs) |
1.78634884662188E-12 |
| Normal-vs-Age(61-80Yrs) |
3.47630000341326E-08 |
| Normal-vs-Age(81-100Yrs) |
4.072400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.069770E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.483940E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.320200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.589600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.101000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.839600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.17175191561137E-12 |
| Normal-VS-Type2 PRCC |
3.61349999999927E-05 |
| Normal-VS-KIRP CIMP |
1.299710E-03 |
| Normal-VS-Unclassified PRCC |
2.30639999998505E-06 |
| Type1 PRCC-VS-Type2 PRCC |
6.120000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.678620E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.289700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.128200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.122400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.746400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.85649999999394E-05 |
| Normal-vs-N1 |
1.96349000000096E-05 |
| Normal-vs-N2 |
2.865400E-01 |
| N0-vs-N1 |
8.236800E-03 |
| N0-vs-N2 |
4.025800E-01 |
| N1-vs-N2 |
8.248400E-02 |
|
|
